Artemisinin - Covid-19 updateHydroxychloroquineResults published...

Artemisinin - Covid-19 update

Hydroxychloroquine
Results published Wednesday by the New England Journal of Medicineshow that hydroxychloroquine was no better than placebo pills at preventingillness from the coronavirus.
https://abcnews.go.com/Health/wireStory/malaria-drug-fails-prevent-covid-19-rigorous-study-71050953

Max Planck Group
The scientists expect results by the end of May at the latest. IfArtemisia is found to be effective in these trials, further tests includingclinical studies on humans, would still need to take place. "But even ifthe hopes for a drug based on the active ingredient against COVID-19 end in adisappointment, it would be a gain," says Seeberger, "above all, itwould bring clarity."

https://www.dw.com/en/covid-19-tests-for-miracle-cure-herb-artemisia-begin/a-53442366

Liverpool School of Tropical Medicine
Artemisininand its derivative artesunate are also among a range ofcompounds being screened against the virus at the Liverpool School of TropicalMedicine, which expects to have results next week.

https://cen.acs.org/biological-chemistry/infectious-disease/Artemisinin-raises-hopes-fears-amid-COVID-19/98/i21

Clinical trial starting June 2020
In this Clinical trial, Investigators will evaluate the effectof Artemisinin / Artesunate on morbidity of COVID-19 patients in decreasing thecourse of the disease and viral load in symptomatic stable positive swabCOVID-19 patients. Investigators are hypothesizing that due to the antiviralproperties of this drug it will help as a treatment for the COVID -19 patients.In improving their condition and clearing the virus load.
https://clinicaltrials.gov/ct2/show/NCT04387240

And Mateon Therapeutics